HowShorted

How shorted is Genprex, Inc.?

9.78%
of shares outstanding reported short · settlement date 15 Jul 2026
vs previous report
−0.59
5 reports (~10 weeks)
−2.62
Aggregate net short position time series for Genprex, Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
15 Jul 20269.78%−0.59
30 Jun 202610.37%−0.72
15 Jun 202611.09%+0.30
29 May 202610.79%−0.65
15 May 202611.44%−0.96
30 Apr 202612.40%+6.81
15 Apr 20265.59%+1.32
31 Mar 20264.27%−16.87
13 Mar 202621.14%−10.12
27 Feb 202631.26%+11.19
13 Feb 202620.07%+11.59
31 Dec 20258.48%0.00
15 Dec 20258.48%+0.19
28 Nov 20258.29%+2.45
14 Nov 20255.84%−0.86
15 Oct 20256.70%+1.38
30 Sep 20255.32%−7.01
15 Sep 202512.33%+4.08
29 Aug 20258.25%+2.49
15 Aug 20255.76%+0.08
31 Jul 20255.68%–

Frequently asked questions

How shorted is Genprex, Inc. right now?
9.78% of Genprex, Inc.'s (GNPX) shares outstanding were reported short for settlement date 15 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.